Need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document reflects the need for a guideline on the evaluation of the safety and efficacy of thrombopoetin receptor agonists fin the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
Keywords: Chronic immune idiopathic thrombocytopenic purpura, ITP, thrombopoeting agonists